New York, NY -- (SBWIRE) -- 01/06/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Gerdau SA (ADR)(NYSE:GGB), Key Energy Services, Inc.(NYSE:KEG), Idera Pharmaceuticals Inc(NASDAQ:IDRA), CytRx Corporation(NASDAQ:CYTR)
Gerdau SA (ADR)(NYSE:GGB) reported gain 0.40% and closed at $7.961 with the total traded volume of 3.81M shares. Its market capitalization is $12.94B. The stock has a 52-week high price of 9.68 and its 52-week low was recorded at $5.27
Gerdau SA is a Brazil-based holding company engaged in the manufacture and sale of steel products. The Company produces long steel and flat steel items, principally through the process of fabrication in electrical furnaces from scrap metal and purchased pig iron, as well as by manufacturing steel from iron ore in the blast furnace and by direct reduction.
What GGB Charts Are Signaling for Traders? Find Out Here
Key Energy Services, Inc.(NYSE:KEG) gain 0.64% and ended at $7.86.The total traded volume was 3.76M shares and market capitalization arrived at $1.20B. The stock has a 52-week high price of $9.55 and its 52-week low was recorded at $5.61, while during last trade its minimum price was $7.79 and it gained the highest price of $7.94.
Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor. The Company provides a range of well services to major oil companies, foreign national oil companies and independent oil and natural gas production companies.
Is KEG Buy After The Recent Price Movement? Find Out Here
Idera Pharmaceuticals Inc(NASDAQ:IDRA)’s reported the increase of 5.05% to close at $4.99 with the overall traded volume of 3.69M shares. Its market capitalization on last close reached to $233.17 million. Its intraday-low price was $4.60 and its hit its day's highest price at $5.30.
Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates.
Should IDRA a Buy or Sell Now? Find Out Here
CytRx Corporation(NASDAQ:CYTR) loss -3.48% settle at $6.66. Its total traded volume during last trading session was 3.65M shares. The overall market worth of this company is about $279.56M. The 52 week range of the stock remained $1.83 - $7.30, while its day's lowest price was $6.55 and its hit its day's highest price at $7.24.
CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology.
What CYTR Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)